Extended possibility to innovate on the payment model for specialist care in the Netherlands

18

Feb 2021

In the Netherlands, medical procedures within medical specialist care can be reimbursed via DRG or via supplementary payments called "Other care products" (Overige zorgproducten, OZPs). The codes of the list of procedure codes (Zorgactiviteiten) within the DRG package are used for coding and billing these supplementary payments. There are four categories of OZPs:

  • Add-on products: add-on for intensive care, add-on medicines, supplementary payments for coagulation factors, etc.);
  • Primary care diagnostics (the services that can be ordered by primary care specialist (GP) and performed within medical specialist care facilities): laboratory diagnostics, imaging diagnostics, nuclear medicine treatment, and diagnostics, etc.);
  • Paramedic treatment and diagnostics (physiotherapy, speech therapy, exercise therapy, optometry, etc.);
  • Other operations (hyperbaric oxygen treatment, cryopreservation of germ cells and embryos, clinical genetic research for genetic counseling, etc.).

There are different reimbursement models for OZPs:

  • Some categories of the OZPs, like primary care diagnostics or paramedic treatment and diagnostics, can be billed and reimbursed separately (fee-for-service), without opening a DRG pathway;
  • The other OZP categories, like an add-on for intensive care or medicines, can be billed and reimbursed only in conjunction with the DRG, on top of the DRG tariff.

OZPs may have nationally determined tariffs (for example, add-on for intensive care or cryopreservation of germ cells and embryos) or free tariffs negotiated between provider and health insurer (for example, primary care diagnostics or physiotherapy). A detailed description of conditions of reimbursement and type of tariffs for supplementary payments is provided in the DRG manual.

In 2019, a new (fifth) type of OZP was established by the Dutch Healthcare Authority (NZa) – the "optional service" (facultatieve prestatie). Optional service is a way for providers and insurers to innovate on the payment model for care, including the creation of new payment categories or replacement of existing payment categories. For example, a bundled diagnostic package was created in 2020 for diagnostics of obstructive sleep apnea instead of three previously existed separate reimbursement categories.

The "Optional service" model is only applicable to well-established care, which is currently provided as part of the Basic Health Insurance. Innovations without proven benefits cannot utilize the "optional service" pathway.

To create a new payment category, at least one provider and at least one insurance company should submit a proposal to the NZa. The NZa approves the category. After the approval, the category can be used nationwide by any providers/insurers. The tariffs for "optional services" are no determined nationally and should be agreed locally between insurers and providers.

From 2020, NZa gave the ability to create innovative payment models only to the first-line diagnostics services. In 2021, this was extended to the add-on reimbursement categories. It means that insurers and providers can agree on add-on reimbursement of some activities or devices, which are not adequately covered by existing DRG reimbursement.

From 2022, NZa expects to extend possibilities for "optional services" to the DRG segment as well.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more